arrow
M

Mariantonia Carosi

regina elena national cancer institute
H指数:23
被引数:1,884

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dissecting endometrial cancer complexity in response to standard and targeted therapies

解析子宫内膜癌对标准疗法和靶向疗法的反应复杂性

2025-11-280
OAAI
Hystero-embryoscopy as a tool for RPL immunological research at the maternal-fetal interface

宫腔-胚胎镜作为复发性流产免疫学研究中母胎界面的一种工具

2025-05-290
PRE
Role of inflammatory blood parameters from complete blood count in predicting ovarian follicular density in cancer patients undergoing ovarian tissue cryopreservation

完整血液计数中的炎症血液参数在预测接受卵巢组织冷冻保存的癌症患者卵泡密度中的作用

2025-04-300
OA
Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer (vol 41, 151, 2022)
2023-10-241
OAAI
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world

里贾纳·埃琳娜国家癌症研究所的分子肿瘤委员会: 从应计到现实世界的治疗

2023-10-164
OAAI
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis

HSF-1/miR-145-5p转录轴增强腹腔热灌注化疗对腹膜卵巢癌的疗效

2023-08-193
OAAI
The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach

神经胶质瘤-IRE项目-神经胶质瘤患者的分子谱分析: 迈向个性化诊断和治疗方法的步骤

2023-03-237
OAAI
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas
2023-03-177
OAAI
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

基于MicroRNA的签名影响卵巢癌的临床过程和生物学: 一项miRNOmics研究

2021-07-1313
OAAI
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?
2019-04-120
PREAI